Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D000243:Adenosine Deaminase / Q000378:metabolism*; D000818:Animals; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009700:Nucleoside Deaminases / Q000378:metabolism*; D012867:Skin / Q000276:immunology; D016038:Skin Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D000225:Adenine